scholarly article | Q13442814 |
P356 | DOI | 10.1016/0306-4530(92)90019-4 |
P698 | PubMed publication ID | 1287681 |
P2093 | author name string | P. Franchimont | |
Timsit-Berthier M | |||
von Frenckell R | |||
J. J. Legros | |||
M. Ansseau | |||
R. von Frenckell | |||
M. Timsit-Berthier | |||
C. Gazzotti | |||
T. Carvelli | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oxytocin | Q169960 |
schizophrenia | Q41112 | ||
apomorphine | Q269111 | ||
AVP | Q12009087 | ||
schizophrenic psychology | Q69941090 | ||
P304 | page(s) | 611-617 | |
P577 | publication date | 1992-11-01 | |
P1433 | published in | Psychoneuroendocrinology | Q7256450 |
P1476 | title | Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics | |
P478 | volume | 17 |
Q30408983 | A Role for Oxytocin in the Etiology and Treatment of Schizophrenia |
Q36740391 | A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies |
Q38192728 | A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery |
Q46895961 | Absence of a difference in the neurosecretory activity of supraoptic nucleus vasopressin neurons of neuroleptic-treated schizophrenic patients |
Q41521990 | Central nervous system actions of oxytocin and modulation of behavior in humans |
Q37022856 | Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls |
Q48484694 | Differential effects of oxytocin on mouse hippocampal oscillations in vitro. |
Q44599218 | Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. |
Q37344122 | Electroencephalographic and early communicative abnormalities in Brattleboro rats. |
Q60937279 | Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia |
Q26770469 | From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders |
Q35823961 | Neurobiology of Maternal Stress: Role of Social Rank and Central Oxytocin in Hypothalamic-Pituitary Adrenal Axis Modulation |
Q35130197 | Neuropeptides involved in the pathophysiology of schizophrenia and major depression |
Q43578957 | Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study |
Q45032796 | Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree |
Q50303936 | Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients |
Q60619756 | Oxytocin bei Schizophrenie |
Q30453929 | Oxytocin in schizophrenia: a review of evidence for its therapeutic effects |
Q28079176 | Oxytocin in the socioemotional brain: implications for psychiatric disorders |
Q30464312 | Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia |
Q37511061 | Oxytocin, vasopressin, and human social behavior |
Q47958004 | Oxytocin-induced yawning: sites of action in the brain and interaction with mesolimbic/mesocortical and incertohypothalamic dopaminergic neurons in male rats |
Q34311629 | Peripheral oxytocin is associated with reduced symptom severity in schizophrenia |
Q36756329 | Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis |
Q33761384 | Potential of Oxytocin in the Treatment of Schizophrenia |
Q37908476 | Prosocial effects of oxytocin and clinical evidence for its therapeutic potential |
Q47818989 | Psychoneuroendocrinology of schizophrenia |
Q34322999 | Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders |
Q43144926 | Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes |
Q30277149 | Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders |
Q46411318 | Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin |
Q36387420 | Stress axis dysfunction in schizophrenia |
Q47745919 | The role of oxytocin in empathy to the pain of conflictual out-group members among patients with schizophrenia. |
Q33994774 | The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings |
Q35035128 | The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects |
Search more.